News for Bioline RX Stock (BLRX)

BioLineRx Ltd. (BLRX) Shareholder Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against BioLineRx Ltd.

Business Wire • 01/21/23

ROSEN, SKILLED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

Newsfile Corp • 01/17/23

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd. (BLRX)

Business Wire • 01/17/23

Bronstein, Gewirtz & Grossman, LLC Notifies BioLineRx Ltd. (BLRX) Investors of Class Action and to Actively Participate

Business Wire • 01/17/23

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioLineRx Ltd.

Business Wire • 01/13/23

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 01/13/23

BLRX NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm - BLRX

PRNewsWire • 01/13/23

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd. (BLRX) Investors

Business Wire • 01/12/23

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of BioLineRx Ltd.

Business Wire • 01/11/23

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 01/11/23

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm - BLRX

Newsfile Corp • 01/10/23

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of BioLineRx Ltd. (BLRX) on Behalf of Investors

Business Wire • 01/10/23

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 01/10/23

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of BioLineRx Ltd.

Business Wire • 01/09/23

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Newsfile Corp • 01/09/23

BIOLINERX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against BioLineRx Ltd.

Business Wire • 01/09/23

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against BioLineRx Ltd. (BLRX)

Business Wire • 01/07/23

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in BioLineRx Ltd. with Losses of $100,000 to Contact the Firm

Business Wire • 01/06/23

BLRX INVESTOR NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Secure Counsel Before Important Deadline in First Filed Securities Class Action Initiated by the Firm - BLRX

PRNewsWire • 01/05/23

EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of BioLineRx Ltd. Investors – BLRX

Business Wire • 01/05/23

BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer

PRNewsWire • 01/04/23

BLRX NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation - BLRX

Newsfile Corp • 01/01/23

BLRX SHAREHOLDER ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation - BLRX

PRNewsWire • 12/31/22

TOP RANKED ROSEN LAW FIRM Encourages BioLineRx Ltd. Investors to Inquire About Securities Class Action Investigation – BLRX

Business Wire • 12/29/22

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

PRNewsWire • 12/20/22